Literature DB >> 16391388

Expression profiling of p53-target genes in copper-mediated neuronal apoptosis.

Jacob W Vanlandingham1, Nadine M Tassabehji, Rikki C Somers, Cathy W Levenson.   

Abstract

Copper toxicity associated with Wilson's disease is known to cause neuronal damage and death in the basal ganglia and frontal cortex leading to Parkinson-like symptoms and cognitive deficits. Our previous work in cultured human NTERA-2-N neurons showed that copper-induced neuronal apoptosis is dependent on the induction and nuclear translocation of the tumor suppressor protein, p53. Because p53 acts as a DNA-binding transcription factor, this work used an oligonucleotide array to identify p53 target genes that are differentially regulated in copper-loaded neurons. Arrays representing 145 human genes expressed downstream of p53 were hybridized with labeled mRNA from control and copper-treated neurons. Differentially regulated mRNAs included those involved in the regulation of the cell cycle, cytoprotective mechanisms, and apoptotic mechanisms. Transfection of cells with a dominant-negative p53 construct enabled us to determine which molecular events were dependent on p53 expression. Copper treatment resulted in the upregulation of p21, reprimo, stathmin, and Tp53INP1, all known to participate in cell cycle arrest. Protective mechanisms included the upregulation of stat-3, and the heat-shock proteins, heat-shock protein (Hsp) 70 and Hsp 27. Both p53-dependent and -independent mechanisms leading to apoptosis were identified including insulin-like growth factor binding protein-6, glutathione peroxidase, bcl-2, RB-1, PUMA, and several members of the redox active PIG family of proteins. Thus it appears that following copper-mediated neuronal DNA damage, the regulation of a variety of pro- and antiapoptotic genes are responsible for determining neuronal fate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16391388     DOI: 10.1385/NMM:7:4:311

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  54 in total

1.  Formation of DNA adducts and oxidative base damage by copper mediated oxidation of dopamine and 6-hydroxydopamine.

Authors:  G Lévay; Q Ye; W J Bodell
Journal:  Exp Neurol       Date:  1997-08       Impact factor: 5.330

2.  The putative helical lid of the Hsp70 peptide-binding domain is required for efficient preprotein translocation into mitochondria.

Authors:  Andreas Strub; Nicole Zufall; Wolfgang Voos
Journal:  J Mol Biol       Date:  2003-12-12       Impact factor: 5.469

3.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

4.  Role of ATP7B in biliary copper excretion in a human hepatoma cell line and normal rat hepatocytes.

Authors:  M Harada; S Sakisaka; K Terada; R Kimura; T Kawaguchi; H Koga; E Taniguchi; K Sasatomi; N Miura; T Suganuma; H Fujita; K Furuta; K Tanikawa; T Sugiyama; M Sata
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

5.  Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.

Authors:  J C Curtin; K H Dragnev; D Sekula; A J Christie; E Dmitrovsky; M J Spinella
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

6.  Overexpression of rat heat shock protein 70 is associated with reduction of early mitochondrial cytochrome C release and subsequent DNA fragmentation after permanent focal ischemia.

Authors:  Daisuke Tsuchiya; Shwuhuey Hong; Yasuhiko Matsumori; Hiroaki Shiina; Takamasa Kayama; Raymond A Swanson; Wolfgang H Dillman; Jialing Liu; S Scott Panter; Philip R Weinstein
Journal:  J Cereb Blood Flow Metab       Date:  2003-06       Impact factor: 6.200

7.  Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome C release and Bax regulation.

Authors:  Q Hou; E Cymbalyuk; S-C Hsu; M Xu; Y-T Hsu
Journal:  Apoptosis       Date:  2003-12       Impact factor: 4.677

8.  Cognitive impairment in Wilson's disease.

Authors:  A Medalia
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

9.  Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions.

Authors:  W Oder; L Prayer; G Grimm; J Spatt; P Ferenci; H Kollegger; B Schneider; A Gangl; L Deecke
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

10.  Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome.

Authors:  N Kaushik; D Fear; S C M Richards; C R McDermott; E F Nuwaysir; P Kellam; T J Harrison; R J Wilkinson; D A J Tyrrell; S T Holgate; J R Kerr
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

View more
  13 in total

1.  Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Svetlana Ghimbovschi; Eric P Hoffman; William J Jusko; Debra C Dubois
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

Review 2.  p53 and mitochondrial function in neurons.

Authors:  David B Wang; Chizuru Kinoshita; Yoshito Kinoshita; Richard S Morrison
Journal:  Biochim Biophys Acta       Date:  2014-01-08

3.  Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy.

Authors:  Kim Nguyen; Jesse J Parry; Buck E Rogers; Carolyn J Anderson
Journal:  Nucl Med Biol       Date:  2011-11-04       Impact factor: 2.408

4.  Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1.

Authors:  Julien Gommeaux; Carla Cano; Stéphane Garcia; Meritxell Gironella; Sylvia Pietri; Marcel Culcasi; Marie-Josèphe Pébusque; Bernard Malissen; Nelson Dusetti; Juan Iovanna; Alice Carrier
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

5.  Gene Expression Profile of NF-κB, Nrf2, Glycolytic, and p53 Pathways During the SH-SY5Y Neuronal Differentiation Mediated by Retinoic Acid.

Authors:  Matheus Augusto de Bittencourt Pasquali; Vitor Miranda de Ramos; Ricardo D Oliveira Albanus; Alice Kunzler; Luis Henrinque Trentin de Souza; Rodrigo Juliani Siqueira Dalmolin; Daniel Pens Gelain; Leila Ribeiro; Luigi Carro; José Cláudio Fonseca Moreira
Journal:  Mol Neurobiol       Date:  2014-12-03       Impact factor: 5.590

6.  Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity.

Authors:  Hsien W Chan; Tianbing Liu; Giuseppe Verdile; Glenda Bishop; Ryan J Haasl; Mark A Smith; George Perry; Ralph N Martins; Craig S Atwood
Journal:  Int J Clin Exp Med       Date:  2008-01-20

7.  Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.

Authors:  Kathleen Saavedra; José Valbuena; Wilda Olivares; María José Marchant; Andrés Rodríguez; Verónica Torres-Estay; Gonzalo Carrasco-Avino; Leda Guzmán; Francisco Aguayo; Juan Carlos Roa; Alejandro H Corvalán
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

8.  Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.

Authors:  Hyun-Kyung Lim; Kyoung Mee Kim; Seong-Yun Jeong; Eun Kyung Choi; Joohee Jung
Journal:  Integr Cancer Ther       Date:  2016-05-05       Impact factor: 3.279

9.  p53 Configures the G2/M Arrest Response of Nucleostemin-Deficient Cells.

Authors:  Guanqun Huang; Lingjun Meng; Robert Y L Tsai
Journal:  Cell Death Discov       Date:  2015-11-23

10.  Biocompatibility of common implantable sensor materials in a tumor xenograft model.

Authors:  Mark E Gray; James Meehan; Ewen O Blair; Carol Ward; Simon P Langdon; Linda R Morrison; Jamie R K Marland; Andreas Tsiamis; Ian H Kunkler; Alan Murray; David Argyle
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2018-10-27       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.